For research use only. Not for therapeutic Use.
Tanuxiciclib is a cyclin dependent kinase (CDK) inhibitor[1].
| Catalog Number | I045093 |
| CAS Number | 1983983-64-7 |
| Synonyms | 6-(2-amino-3-fluoropyridin-4-yl)-2-(2-amino-6-methylpyrimidin-4-yl)pyridin-3-ol |
| Molecular Formula | C15H13FN6O |
| Purity | ≥95% |
| InChI | InChI=1S/C15H13FN6O/c1-7-6-10(22-15(18)20-7)13-11(23)3-2-9(21-13)8-4-5-19-14(17)12(8)16/h2-6,23H,1H3,(H2,17,19)(H2,18,20,22) |
| InChIKey | UQHDKUFLWKTTDL-UHFFFAOYSA-N |
| SMILES | CC1=CC(=NC(=N1)N)C2=C(C=CC(=N2)C3=C(C(=NC=C3)N)F)O |
| Reference | [1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021. |
